← Product Code [IMG](/submissions/PM/subpart-f%E2%80%94physical-medicine-therapeutic-devices/IMG) · K023050 # RELIANT BTL 5000 PULS ELECTRICAL STIMULATION SYSTEM, RELIANT BTL 5000 SONO ULTRASOUND SYSTEM, RELIANT BTL 5000 COMBI (K023050) _Reliant Technologies, Inc. · IMG · Feb 14, 2003 · Physical Medicine · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/PM/subpart-f%E2%80%94physical-medicine-therapeutic-devices/IMG/K023050 ## Device Facts - **Applicant:** Reliant Technologies, Inc. - **Product Code:** [IMG](/submissions/PM/subpart-f%E2%80%94physical-medicine-therapeutic-devices/IMG.md) - **Decision Date:** Feb 14, 2003 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 890.5860 - **Device Class:** Class 2 - **Review Panel:** Physical Medicine - **Attributes:** Therapeutic ## Indications for Use The Reliant BTL 5000 Puls Electrical Stimulation System, BTL 5000 Sono Ultrasound System, and BTL 5000 Combi Combination Electrical Stimulation & Ultrasound systems (and the delivery accessories that are used with them) are indicated for use in the stimulating, relaxing, and/or repeatedly contracting muscles by passing electrical currents through electrodes contacting the affected body area in the medical specialties of physical medicine, general and plastic surgery and neurology and/or for use in applying therapeutic deep heat for selected medical conditions such as relief of pain, muscle spasms, and joint contractures in the medical specialty of physical medicine. The Reliant BTL 5000 Puls Electrical Stimulation System, BTL 5000 Sono Ultrasound System, and BTL 5000 Combi Combination Electrical Stimulation & Ultrasound systems are indicated for the treatment and relaxation of muscle spasms, prevention or retardation of disuse atrophy, increasing local blood circulation, muscle re-education, maintaining or increasing range of motion, immediate post-surgical stimulation of calf muscles to prevent venous thrombosis, symptomatic relief of chronic, intractable pain, management of pain associated with post-traumatic or post-operative conditions using electrical stimulation and are indicated for the application of therapeutic deep heat for the treatment of selected medical conditions such as relief of pain, muscle spasms and joint contractures, relief of pain, muscle spasms and joint contractures that may be associated with adhesive capsulitis, bursitis with slight calcification, myositis, soft tissue injuries, shortened tendons due to past injuries and scar tissues, relief of chronic and subchronic pain and joint contractures resulting from capsular tightness and capsular scarring using ultrasound. The combination ultrasound and electrotherapy modes deliver deep heat for pain management (ultrasound therapy) at the same time that electrical stimulation for either pain management or muscle stimulation is being delivered. Only one electrotherapy mode (TENS, High Voltage, Interferential or Premodulated) can be utilized at a time in conjunction with the ultrasound mode. ## Device Story System console with software/electronics, control panel, and delivery accessories (cables, electrodes, ultrasound sound heads). Operates by delivering electrical currents (TENS, Russian, High Voltage, Microcurrent, Interferential, Premodulated) or therapeutic ultrasound deep heat. Used in physical medicine, surgery, and neurology clinics by healthcare providers. Combination mode allows simultaneous ultrasound and one electrotherapy modality. Output provides muscle stimulation or deep heat therapy to manage pain, spasms, and contractures; improve circulation; and prevent atrophy. Benefits include non-invasive pain management and physical rehabilitation support. ## Clinical Evidence No clinical data. Substantial equivalence demonstrated via validation documentation and comparison of technical characteristics and features. ## Technological Characteristics System console with control electronics and software; delivery via electrodes/sponge covers and ultrasound sound heads. Modalities: TENS, Russian, High Voltage, Microcurrent, Interferential, Premodulated, and Ultrasound. Class II device. Connectivity: Standalone console. ## Regulatory Identification An ultrasound and muscle stimulator for use in applying therapeutic deep heat for selected medical conditions is a device that applies to specific areas of the body ultrasonic energy at a frequency beyond 20 kilohertz and that is intended to generate deep heat within body tissues for the treatment of selected medical conditions such as relief of pain, muscle spasms, and joint contractures, but not for the treatment of malignancies. The device also passes electrical currents through the body area to stimulate or relax muscles. ## Predicate Devices - Chattanooga Group, Inc. Vectra 2C and Vectra 4C ([K982317](/device/K982317.md)) - Chattanooga Group, Inc. Vectra Pro 2 and Vectra Pro 4 ([K982324](/device/K982324.md)) - Dynatronics Corporation Dynatron 150 Plus Ultrasound ([K935728](/device/K935728.md)) - Excel Tech XL Tek Ultra VM Ultrasound ([K001166](/device/K001166.md)) - Empi 300 PV Complete Electrotherapy System ([K021100](/device/K021100.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ ## Attachment 15 510(k) Summary Statement for the Reliant BTL 5000 Puls Electrical Stimulation, BTL 5000 Sono Ultrasound, & BTL 5000 Combi Combination Electrical Stimulation & Ultrasound Systems #### I. General Information | Submitter: | Reliant Technologies, Inc.
260 Sheridan Avenue
Suite 208
Palo Alto, CA 94306 | |---------------------------|-----------------------------------------------------------------------------------------------------------------| | Contact Person: | Anne C Worden
Principal Regulatory Consultant
AL Voss Associates
P.O. Box 405
Angels Camp, CA 95221 | | Summary Preparation Date: | September 11, 2002 | #### II. Names | Device Names: | Reliant BTL 5000 Puls Electrical Stimulation System
Reliant BTL 5000 Sono Ultrasound System
Reliant BTL 5000 Combi Combination Electrical
Stimulation & Ultrasound System | |------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Primary Classification Name: | Ultrasound and Muscle Stimulator (and Accessories) | #### III. Predicate Devices - · Chattanooga Group, Inc. Vectra 2C and Vectra 4C (K982317); - · Chattanooga Group, Inc. Vectra Pro 2 and Vectra Pro 4 (K982324); - · Dynatronics Corporation Dynatron 150 Plus Ultrasound (K935728); - · Excel Tech XL Tek Ultra VM Ultrasound (K001166); and - · Empi 300 PV Complete Electrotherapy System (K021100). #### IV. Product Description Reliant BTL 5000 Puls Electrical Stimulation System, BTL 5000 Sono Ultrasound System, and BTL 5000 Combi Combination Electrical Stimulation & Ultrasound systems are comprised of the following main components: - A system console (including software and control electronics); . - A control and display panel; ● - . Delivery device accessories (patient cables and electrodes and/or ultrasound cables and sound heads. Premarket Notification, 510(k) Submission for: {1}------------------------------------------------ #### Indications for Use V. The Reliant BTL 5000 Puls Electrical Stimulation System, BTL 5000 Sono Ultrasound System, and BTL 5000 Combi Combination Electrical Stimulation & Ultrasound systems (and the delivery accessories that are used with them) are indicated for use in the stimulating, relaxing, and/or repeatedly contracting muscles by passing electrical currents through electrodes contacting the affected body area in the medical specialties of physical medicine, general and plastic surgery and neurology and/or for use in applying therapeutic deep heat for selected medical conditions such as relief of pain, muscle spasms, and joint contractures in the medical specialty of physical medicine. The Reliant BTL 5000 Puls Electrical Stimulation System, BTL 5000 Sono Ultrasound System, and BTL 5000 Combi Combination Electrical Stimulation & Ultrasound systems are indicated for the treatment and relaxation of muscle spasms, prevention or retardation of disuse atrophy, increasing local blood circulation, muscle re-education, maintaining or increasing range of motion, immediate post-surgical stimulation of calf muscles to prevent venous thrombosis, symptomatic relief of chronic, intractable pain, management of pain associated with post-traumatic or post-operative conditions using electrical stimulation and are indicated for the application of therapeutic deep heat for the treatment of selected medical conditions such as relief of pain, muscle spasms and joint contractures, relief of pain, muscle spasms and joint contractures that may be associated with adhesive capsulitis, bursitis with slight calcification, myositis, soft tissue injuries, shortened tendons due to past injuries and scar tissues, relief of chronic and subchronic pain and joint contractures resulting from capsular tightness and capsular scarring using ultrasound. The combination ultrasound and electrotherapy modes deliver deep heat for pain management (ultrasound therapy) at the same time that electrical stimulation for either pain management or muscle stimulation is being delivered. Only one electrotherapy mode (TENS, High Voltage, Interferential or Premodulated) can be utilized at a time in conjunction with the ultrasound mode. #### VI. Rationale for Substantial Equivalence The Reliant BTL 5000 Puls Electrical Stimulation System, BTL 5000 Sono Ultrasound System, and BTL 5000 Combi Combination Electrical Stimulation & Ultrasound systems share the same general indications for use in physical medicine, general and plastic surgery and neurology applications and share the same or similar basic characteristics and features and, therefore, are substantially equivalent to the Chattanooga Group, Inc. Vectra 2C and Vectra 4C (K982317), the Chattanooga Group, Inc. Vectra Pro 2 and Vectra Pro 4 (K982324), the Dynatronics Corporation Dynatron 150 Plus Ultrasound (K935728) , the Excel Tech XL Tek Ultra VM Ultrasound (K001166), and the Empi 300 PV Complete Electrotherapy (K021100) systems. #### VII. Safety and Effectiveness Information Validation documentation and a comparison of the technical characteristics and features were provided to demonstrate that the Reliant BTL 5000 Puls Electrical Stimulation System, BTL 5000 Sono Ultrasound System, and BTL 5000 Combi Combination Electrical Stimulation & Ultrasound systems are safe and effective, when indicated in specific applications in the medical specialties of physical medicine, general and plastic surgery and neurology. {2}------------------------------------------------ ### VIII. Conclusion The Reliant BTL 5000 Puls Electrical Stimulation System, BTL 5000 Sono Ultrasound System, and BTL 5000 Combination Electrical Stimulation & Ultrasound systems were found to be substantially equivalent to the predicate Chattanooga Group, Inc. Vectra 2C and Vectra 4C (K982317), the Chattanooga Group, Inc. Vectra Pro 2 and Vectra Pro 4 (K982324), the Dynatronics Corporation Dynatron 150 Plus Ultrasound (K935728), the Excel Tech XL Tek Ultra VM Ultrasound (K001166), and the Empi 300 PV Complete Electrotherapy (K021100) systems. The Reliant BTL 5000 Puls Electrical Stimulation System, BTL 5000 Sono Ultrasound System, and BTL 5000 Combi Combination Electrical Stimulation & Ultrasound systems share similar indications for use and characteristics and functional features, and thus are substantially equivalent to, the currently marketed predicate devices. {3}------------------------------------------------ Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle or bird-like figure with three curved lines representing its body and wings. The logo is encircled by the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" in a circular arrangement. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 FEB 1 4 2003 Reliant Technologies, Inc. C/O: Ms. Anne Worden AL Voss Associates P.O. Box 405 Angels Camp, CA 95221 Re: K023050 Dated: January 3, 2003 Received: January 6, 2003 Trade/Device Name: BTL 5000 Combi Electrical Stimulation & Ultrasound System with rubber electrodes and sponge covers Regulation Numbers: 21 CFR 890.5860, 21 CFR 882.5890, 21 CFR 882.1320 Regulation Names: Ultrasound and muscle simulator, transcutaneous electrical nerve stimulator for pain relief, cutaneous electrodes Regulatory Class: Class II Product Codes: IMG, GZJ, GXY, LIH Trade/Device Name: BTL 5000 Puls Electrical Stimulation System with rubber electrodes and sponge covers Regulation Numbers: 21 CFR 890.5850, 21 CFR 882.5890, 21 CFR 882.1320 Regulation Names: Powered muscle stimulator, transcutaneous electrical nerve stimulator for pain relief, cutaneous electrodes Regulatory Class: Class II Product Codes: IPF, GZJ, GXY, LIH Trade/Device Name: BTL 5000 Sono Ultrasound System Regulation Number: 21 CFR 890.5300 Regulation Name: Ultrasound diathermy Regulatory Class: Class II Product Code: IMI Dear Ms. Worden: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976. the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. {4}------------------------------------------------ ## Page 2 - Ms. Worden If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html Sincerely yours, Mark N. Milkuson Celia M. Witten, Ph.D., M.D Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosures {5}------------------------------------------------ # Attachment 2 Indications For Use Statement as Requested by FDA 510(k) Number (if Known): K023050 Device Name: Reliant BTL 5000 Puls Electrical Stimulation System, BTL 5000 Sono Ultrasound System, and BTL 5000 Combination Electrical Stimulation & Ultrasound System Indications For Use: The Reliant BTL 5000 Puls Electrical Stimulation System and the BTL 5000 Combi Combination Electrical Stimulation & Ultrasound System (and the delivery accessories that are used with them) are indicated for use in the medical specialties of physical medicine, general and plastic surgery and neurology for medical purposes/applications requiring: Electrical Stimulation for Muscle & Soft Tissue Stimulation/Pain Management: TENS, Russian, High Voltage Therapy Modes - Treatment and relaxation of muscle spasms . - Prevention or retardation of disuse atrophy . - Increasing local blood circulation . - Muscle re-education . - Maintaining or increasing range of motion . - Immediate postoperative/post-surgical stimulation of calf muscles to prevent venous . thrombosis TENS, Microcurrent, Interferential and Premodulated Modes - Symptomatic relief of chronic and/or intractable pain . - Management of acute pain associated with post-traumatic or post-operative conditions . ## *** Continued on Following Page (page 1 of 2)*** (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) for (Division Sign-Off) Division of General. Restorative and Neurological Devices Prescription Use (Per 21 CFR 801.109) OR Over-The-Counter Use 510(k) Number K023050 (Optional Format 1-2-96) Attachment 2 - Page 1 Page Revised 02/05/2003 {6}------------------------------------------------ # Attachment 2 Indications For Use Statement as Requested by FDA K023050 510(k) Number (if Known): Device Name: Reliant BTL 5000 Puls Electrical Stimulation System, BTL 5000 Sono Ultrasound System, and BTL 5000 Combi Combination Electrical Stimulation & Ultrasound System Indications For Use: ## ***Continued from Previous Page (page 2 of 2)*** The Reliant BTL 5000 Sono Ultrasound System and the BTL 5000 Combi Combination Electrical Stimulation & Ultrasound System (and the delivery accessories that are used with them) are indicated for use in the medical specialty of physical medicine for medical purposes/applications requiring: Ultrasound for Deep Heat/Pain Management: - · Application of therapeutic deep heat for the treatment of selected chronic and subchronic medical conditions such as: - > Relief of pain, muscle spasms and joint contractures - Relief of pain, muscle spasms and joint contractures that may be associated with: > - Adhesive capsulitis . - Bursitis with slight calcification . - . Myositis - Soft tissue injuries . - Shortened tendons due to past injuries and scar tissues . - Relief of chronic and subchronic pain and joint contractures resulting from: > - Cansular tightness ● - Capsular scarring . The combination ultrasound and electrotherapy modes deliver deep heat for pain management (ultrasound therapy) at the same time that electrical stimulation for either pain management or muscle stimulation is being delivered. Only one electrotherapy mode (TENS, High Voltage. Interferential or Premodulated) can be utilized at a time in conjunction with the ultrasound mode. (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ Prescription Use (Per 21 CFR 801.109) OR Over-The-Counter Use (Optional Format 1-2-96) Premarket Notification, 510(k) Submission for: Reliant BTL 5000 Puls Electrical Stimulation, BTL 5000 Sono Ultrasound & BTL 5000 Combi Electrical Stimulation & Ultrasound Systems Attachment 2 - Page 2 Page Revised 02/05/2003 --- **Source:** [https://fda.innolitics.com/submissions/PM/subpart-f%E2%80%94physical-medicine-therapeutic-devices/IMG/K023050](https://fda.innolitics.com/submissions/PM/subpart-f%E2%80%94physical-medicine-therapeutic-devices/IMG/K023050) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com